Browse > Article

Effects of Hydrophilic Additives on the Release Rate of Protein Drugs  

Kwon, Young-Kwan (School of Chemical and Biological Engineering, Seoul National University)
Kim, Ji-Hyeon (Department of Chemical and Biochemical Engineering, Dongguk University)
Yoo, Young-Je (School of Chemical and Biological Engineering, Seoul National University)
Publication Information
KSBB Journal / v.22, no.4, 2007 , pp. 213-217 More about this Journal
Abstract
It has been reported that hydrophobic additives generally decrease the release rate of protein drugs from drug delivery systems (DDS) and hydrophilic additives increase the release rate. In many cases, however, the addition of hydrophilic molecule is necessary for improving the stability of protein drugs. In the present work, the effects of hydrophilic additives on the release profiles, and micelle formation of protein drug formulations were investigated to develop a novel method for protein drug delivery. For model protein drug, bovine serum albumin (BSA) was employed and several hydrophilic additives were used in the release experiments. Hydrophilic additive D-sorbitol showed the lower release rates of BSA than other hydrophobic additives due to the gel strengthening ability of the additive and the optimum concentration of D-sorbitol was 3 w/v % for the retarded release rate. In addition, it was found that the addition of D-sorbitol was very effective for obtaining homogeneous and stable DDS. The results were discussed in terms of the micelle formation and the micelle structure, i.e., the differences in gel structure and the distribution of drugs in micelles.
Keywords
Protein drug formulation; drug delivery; pluronics; additive; D-sorbitol;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Kabanov, A. V., E. V. Batrakova, N. S. Melik-Nubarov, N. A. Fedoseev, T. U. Dorodnich, V. Y. Alakhov, V. P. Chekhonin, I. R. Nazarova, and V. A. Kabanov (1992), A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcantainers for drug targeting from blood in brain, J. Cont. Relaease 22, 141-157   DOI   ScienceOn
2 Miller, S. C. and M. D. Donovan (1982), Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits, Int. J. Pharm. 12, 147-152   DOI   ScienceOn
3 Desai, S. D. and J. Blanchard (1998), In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpin, Pharm. Sci. 87, 226-230   DOI   ScienceOn
4 Urtti, A., M. Juslin, and O. Minalainen (1985), Pilocarpine release from hydroxypropyl-cellulose-polyvinylpyrrolidone matrices, Int. J. Pharm. 25, 165-178   DOI   ScienceOn
5 Alexandridis, P. and T. A. Hatton (1995), Poly(ethylene oxide)poly( propylene oxide)-poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling, Colloid & Surfaces A 96, 1-46   DOI   ScienceOn
6 Alexandridis, P., D. Zhou, A. Khan (1996), Lyotropic Liquid Crystallinity in Amphiphilic Block Copolymers: Temperature Effects on Phase Behavior and Structure for Poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) Copolymers, Langmuir 12, 2690-2700   DOI   ScienceOn
7 Schmolka, I. R. (1991), Poloxamers in the Pharmaceutical Industry. In Polymers for Controlled Drug Delivery, P. J. Tarcha Eds., p189, CRC Press Boca Raton
8 Joshi, A., S. Ding, and K. J. Himmelstein (1993), US Patent 5, 252318
9 Choi, C-S., S.-M. Park, W.-H. Song, C.-M. Lee, K.-Y. Lee, D.-W. Kim, and J.-C. Kim (2003), Release properties of BSA from pectin beads for colonic drug delivery, Kor. J. Biotechnol. 18, 161-164
10 Katakam, M., L. N. Bell, and A. K. Banga (1995), Effect of surfactants on the physical stability of recombinant human growth hormone, J. Pharm. Sci. 84, 713-716   DOI   ScienceOn
11 Bhardwaj, R. and J. Blanchard (1996), Using poloxamer 407 controlled-release delivery system for the $\alpha$-MSH analogue melatan-I, J. Pharm. Sci. 85, 915-919   DOI   ScienceOn
12 Fix, J. A. (1996), Oral controlled release technology for peptides: status and future prospects, Pharm. Res. 13, 1760-1764   DOI
13 Johnston, T. P., M. A. Punjabi, and C. J. Froelich (1992), Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice, Pharm. Res. 9, 425-434   DOI
14 Guzman, M., F. F. Garcia, and M. R. Aberturas (1992), Polyoxyethylene-polyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration, Int. J. Pharm. 80, 119-127   DOI   ScienceOn
15 Andrianov, A. K. and L. G. payne (1998), Polymeric carriers for oral uptake of microparticulates, Adv. Drug Deliv. Rev. 24, 155-170
16 Waring, G. O. and R. R. Harris (1979), Double masked evaluation of poloxamer artificial tear in keratoconjunctivitis. In Symposium on Ocular Therapy. Vol. 11, J. H. Leopold and R. P. Burnsm, Eds., p127, Wiley, N.Y.
17 Schmolka, I. R. (1972), Artificial skin. Preparation and properties of pluronic F-127 gels for the treatment of burns, J. Biomed Mat. Res. 6, 571-582   DOI
18 Kim, M. S., K. S. Sea, H. Hyun, G. Khang, S. H. Cho, and H. E. Lee (2006), Controlled Release of bovine serum albumin using MPEG-PCL diblock copolymers as implantable protein carriers, J. Appl. Pol. Sci. 102, 1561-1567   DOI   ScienceOn
19 Ford, J. L. M. H. Rubinstein, F. McCaul, and J. E. Edgar (1987), Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets, Int. J. Pharm. 40, 223-224   DOI   ScienceOn